Intrinsic imperfections of endocrine replacement therapy

European Journal of Endocrinology

Volumn 149, Issue 2, 2003, Pages 91-97

  Romijn, J A ^a,b   Smit, J W A ^a,b   Lamberts, S W J ^a,b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ROTTERDAM UNIVERSITY OF APPLIED SCIENCES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; CALCIUM; CORTICOSTEROID; DEXAMETHASONE; ESTROGEN; FLUDROCORTISONE; GROWTH HORMONE; HORMONE RECEPTOR; HYDROCORTISONE; INSULIN; LEVOTHYROXINE; LIOTHYRONINE; MINERALOCORTICOID; PRASTERONE; PREDNISONE; SOMATOMEDIN C; TESTOSTERONE; THYROTROPIN; VITAMIN D DERIVATIVE;

ADRENAL INSUFFICIENCY; CLINICAL PRACTICE; DRUG BLOOD LEVEL; DRUG HALF LIFE; FEMALE; GENETIC VARIABILITY; GROWTH HORMONE DEFICIENCY; HORMONE DEFICIENCY; HORMONE RELEASE; HORMONE SENSITIVITY; HORMONE SUBSTITUTION; HUMAN; HYPOALDOSTERONISM; HYPOGONADISM; HYPOPARATHYROIDISM; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; SHORT SURVEY;

ADRENAL CORTEX HORMONES; DIABETES MELLITUS, TYPE 1; GROWTH HORMONE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGLYCEMIC AGENTS; HYPOGONADISM; HYPOPARATHYROIDISM; INSULIN; THYROID HORMONES;

EID: 0043026914     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1490091     Document Type: Short Survey

References (27)

1. Carr D, McLeod DT, Parry G & Thornes HM. Fine adjustment of thyroxine replacement dosage: comparison of the thyrotrophin releasing hormone test using a sensitive thyrotrophin assay with measurement of free thyroid hormones and clinical assessment. Clinical Endocrinology 1988 28 325-333.
2. Bunevicius R, Kazanavicius G, Zalinkevicius R & Prange AJJ. Effects of thyroxine as compared with thyroxine plus triiodothyronine in patients with hypothyroidism. New England Journal of Medicine 1999 340 424-429.
3. Escobar-Morreale HF, del Rey FE, Obregon MJ & de Escobar GM. Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology 1996 137 2490-2502.
4. Tannenbaum GS, Choi HK, Gurd W & Waxman DJ. Temporal relationship between the sexually dimorphic spontaneous GH secretary profiles and hepatic STAT5 activity. Endocrinology 2001 142 4599-4606.
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine 1993 329 977-986.
6. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes 1997 46 271-286.
7. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S & Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001 24 1858-1862.
8. Zelissen PM, Croughs RJ, van Rijk PP & Raymakers JA. Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. Annals of Internal Medicine 1994 120 207-210.
9. Esteban NV, Loughlin T, Yergey AL, Zawadzki JK, Booth JD, Winterer JC et al. Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. Journal of Clinical Endocrinology and Metabolism 1991 72 39-45.
10. Lamberts SW, Bruining HA & de Jong FH. Corticosteroid therapy in severe illness. New England Journal of Medicine 1997 337 1285-1292.
11. Oelkers W, Diederich S & Bahr V. Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone. Journal of Clinical Endocrinology and Metabolism 1992 75 259-264.
12. Thompson DG, Mason AS & Goodwin FJ. Mineralocorticoid replacement in Addison's disease. Clinical Endocrinology 1979 10 499-506.
13. Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M et al. Dehydroepiandrosterone replacement in women with adrenal insufficiency. New England Journal of Medicine 1999 341 1013-1020.
14. Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA et al. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. Journal of Clinical Endocrinology and Metabolism 2000 85 4650-4656.
15. Wang C, Alexander G, Berman N, Salehian B, Davidson T, McDonald V et al. Testosterone replacement therapy improves mood in hypogonadal men - a clinical research center study. Journal of Clinical Endocrinology and Metabolism 1996 81 3578-3583.
16. Dobs AS, Meikle AW, Arver S, Sanders SW, Caramelli KE & Mazer NA. Pharmacokinetics, efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. Journal of Clinical Endocrinology and Metabolism 1999 84 3469-3478.
17. Arlt W, Fremerey C, Callies F, Reincke M, Schneider P, Timmermann W et al. Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. European Journal of Endocrinology 2002 146 215-222.
18. Spencer CA, LoPresti JS, Patel A, Guttler RB, Eigen A, Shen D et al. Applications of a new chemiluminometric thyrotropin assay to subnormal measurement. Journal of Clinical Endocrinology and Metabolism 1990 70 453-460.
19. Huizenga NA, Koper JW, de Lange P, Pols HA, Stolk RP, Grobbee DE et al. Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. Journal of Clinical Endocrinology and Metabolism 1998 83 47-54.
20. Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Burger H et al. A polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo. Journal of Clinical Endocrinology and Metabolism 1998 83 144-151.
21. van Rossum EF, Huizenga NA, Uitterlinden AG, Janssen JA, Brinkmann AO, de Jong FH et al. Identification of a restriction site polymorphism in the glucocorticoid receptor gene: association with increased sensitivity to glucocorticoids in vivo, corticosteroid-binding globulin and systolic blood pressure. 84th Annual Meeting of the Endocrine Society, San Francisco 2002 OR-49-41.
22. van Rossum EF, Koper JW, Uitterlinden AG, Huizenga NA, Janssen JA, Brinkmann, AO et al. A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with a healthier metabolic profile. 84th Annual Meeting of the Endocrine Society, San Francisco 2002 P3-334.
23. Zitzmann M, Brune M, Kornmann B, Gromoll J, Junker R & Nieschlag E. The CAG repeat polymorphism in the androgen receptor gene affects bone density and bone metabolism in healthy males. Clinical Endocrinology 2001 55 649-657.
24. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A et al. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001 50 637-642.
25. Vaessen N, Janssen JA, Heutink P, Hofman A, Lamberts SW, Oostra BA et al. Association between genetic variation in the gene for insulin-like growth factor-I and low birthweight. Lancet 2002 359 1036-1037.
26. van den Beld A, Huhtaniemi IT, Pettersson KS, Pols HA, Grobbee DE, de Jong FH et al. Luteinizing hormone and different genetic variants, as indicators of frailty in healthy elderly men. Journal of Clinical Endocrinology and Metabolism 1999 84 1334-1339.
27. Herrington DM, Howard TD, Hawkins GA, Reboussin DM, Xu J, Zheng SL et al. Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. New England Journal of Medicine 2002 346 967-974.